During Q4-2012, US IOL surgery volume grew at a rate of 4 percent, slightly higher than long-term trends.
Economic concerns continued to plague the US refractive surgery market in Q4-2012, according to our latest survey data.
Global demand for refractive surgery is expected to grow at a compounded annual rate of roughly 6 percent through 2017.
India offers an interesting refractive market opportunity that is representative in many ways of the emerging market opportunities worldwide.
On February 1, the Centers for Medicare and Medicaid Services released its long-awaited final regulations regarding how drug and medical device companies disclose financial relationships with physicians.
The global market for surgical instruments is expected to approach $950 million in 2013 and to grow to $1.2 billion by 2018.
The medical community erupted in applause on February 14 as the FDA approved Second Sight’s Argus II Retinal Prosthesis System for the treatment of retinitis pigmentosa.
You are not currently logged in.
©2018 Market Scope
Lost your Password